Illumina Inc (NASDAQ:ILMN)

300.91
Delayed Data
As of Sep 13
 +3.39 / +1.14%
Today’s Change
263.30
Today|||52-Week Range
380.76
+0.33%
Year-to-Date
Illumina (ILMN) Gains As Market Dips: What You Should Know
Sep 13 / Zacks.com - Paid Partner Content
ETFs to Gain From the Booming Genomics Market
Sep 04 / Zacks.com - Paid Partner Content
Illumina Banks on New Product Suite Despite Margin Woes
Sep 09 / Zacks.com - Paid Partner Content
Merger or Not, Pacific Biosciences Needs to Deliver
Sep 04 / MotleyFool.com - Paid Partner Content
Probability 101: How Not to Be a Sucker
Sep 05 / Zacks.com - Paid Partner Content
Top-Performing Biotech ETFs YTD
Sep 03 / Zacks.com - Paid Partner Content
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
Sep 04 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close297.52
Today’s open297.86
Day’s range297.81 - 303.68
Volume1,261,318
Average volume (3 months)1,113,159
Market cap$44.2B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+13.15%
Earnings growth (this year)+6.09%
Earnings growth (next 5 years)+16.60%
Revenue growth (last year)+21.11%
P/E ratio47.8
Price/Sales13.33
Price/Book11.77

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+4.32+1.86%
EXASExact Sciences Corp-1.98-1.82%
BMRNBiomarin Pharmaceuti...-0.15-0.21%
NBIXNeurocrine Bioscienc...+2.28+2.42%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 22, 2019
EPS forecast (this quarter)$1.41
Annual revenue (last year)$3.3B
Annual profit (last year)$826.0M
Net profit margin24.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Senior Vice President-Global Quality &
Operations
Robert P. Ragusa
Corporate headquarters
San Diego, California

Forecasts